Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5, signaling a new build of the study details page. The update appears to be a backend or layout revision without changes to the study data.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study data or text across the page appears to have changed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe study record now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor editorial update to the page rather than a change to the trial details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This indicates a minor backend or formatting update with no substantive changes to the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedNew help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The formatting and display of sponsor information and study-section labels were updated (e.g., 'Intervention/Treatment' vs 'Intervention / Treatment'), and versioning details like 'Revision: v3.6.0' were introduced.SummaryDifference1%

- Check71 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the study record display.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.